Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions.

Published in: Head & neck (2020)

ICIs demonstrate their efficacies for R/M HNSCC patients. The incorporation of ICIs showed a great impact on the treatment landscape of HNSCC.

Keyphrases